Injection of TNF provokes systemic inflammation that is driven by RIPK1 kinase-dependent cell death (Duprez et al., 2011) and resembles clinical SIRS (Tracey et al., 1986). Here, RIPK1 is linked to systemic inflammatory response syndrome.